Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Molecules (Basel, Switzerland)
|
January 26, 2012
Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophy
Linda J Popplewell, Aseel Abu-Dayya, Tushar Khanna, et al.
Human Molecular Genetics
|
January 5, 2002
Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE
Julian D Harris, Ian R Graham, Silke Schepelmann, et al.
Human Gene Therapy
|
February 4, 2014
Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors
Hanna Kymäläinen, J Uwe Appelt, Frank A Giordano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2011
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Christophe Pichavant, Annemieke Aartsma-Rus, Paula R Clemens, et al.
Rejuvenation Research
|
May 2, 2009
Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle
Keith Foster, Ian R Graham, Anthony Otto, et al.
Human Molecular Genetics
|
June 17, 2006
Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice
Kaori Ito, Shigemi Kimura, Shiro Ozasa, et al.
BMC Neurology
|
July 3, 2013
Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy
Vered Raz, Ellen Sterrenburg, Samantha Routledge, et al.
Human Molecular Genetics
|
July 6, 2016
Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles
Cécile Peccate, Amédée Mollard, Maëva Le Hir, et al.
Nucleic Acids Research
|
December 20, 2015
piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts
Mariana Loperfido, Susan Jarmin, Sumitava Dastidar, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 8, 2020
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
Haiyan Zhou, Jinhong Meng, Alberto Malerba, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Molecules (Basel, Switzerland)
|
January 26, 2012
Novel cationic carotenoid lipids as delivery vectors of antisense oligonucleotides for exon skipping in Duchenne muscular dystrophy
Linda J Popplewell, Aseel Abu-Dayya, Tushar Khanna, et al.
Human Molecular Genetics
|
January 5, 2002
Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE
Julian D Harris, Ian R Graham, Silke Schepelmann, et al.
Human Gene Therapy
|
February 4, 2014
Long-term episomal transgene expression from mitotically stable integration-deficient lentiviral vectors
Hanna Kymäläinen, J Uwe Appelt, Frank A Giordano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2011
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Christophe Pichavant, Annemieke Aartsma-Rus, Paula R Clemens, et al.
Rejuvenation Research
|
May 2, 2009
Adeno-associated virus-8-mediated intravenous transfer of myostatin propeptide leads to systemic functional improvements of slow but not fast muscle
Keith Foster, Ian R Graham, Anthony Otto, et al.
Human Molecular Genetics
|
June 17, 2006
Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice
Kaori Ito, Shigemi Kimura, Shiro Ozasa, et al.
BMC Neurology
|
July 3, 2013
Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy
Vered Raz, Ellen Sterrenburg, Samantha Routledge, et al.
Human Molecular Genetics
|
July 6, 2016
Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles
Cécile Peccate, Amédée Mollard, Maëva Le Hir, et al.
Nucleic Acids Research
|
December 20, 2015
piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts
Mariana Loperfido, Susan Jarmin, Sumitava Dastidar, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 8, 2020
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
Haiyan Zhou, Jinhong Meng, Alberto Malerba, et al.
Page
of 11